Cardiology, Grenoble Alpes University Hospital, France.

Gilles Barone-Rochette is a distinguished French cardiologist, currently a Professor of Cardiology at Grenoble Alpes University Hospital. With an extensive academic background, including an MD and PhD, he has significantly contributed to cardiovascular research and education. As the leader of multiple research units and the Competence Centre for Cardiomyopathies, his work focuses on innovative cardiovascular imaging and interventional cardiology. Additionally, Barone-Rochette has dedicated over two decades to teaching medical students and residents, shaping future cardiologists. His active involvement in prestigious medical societies and leadership roles further underscores his exceptional qualifications for the Research for Excellence in Research award.

Publication Profile :

Scopus

Academic Qualifications :

Barone-Rochette’s extensive education, from his medical studies at the University of Montpellier to multiple specialized diplomas and certifications, highlights his commitment to excellence in cardiology. His research-focused scholarship on arterial properties post-coronary syndrome underscores his dedication to innovative studies in cardiovascular health, establishing him as a well-rounded expert in the field.

Professional Experience :

Gilles Barone-Rochette has extensive professional experience in cardiology, currently serving as a Professor of Cardiology and a leading researcher at Grenoble Alpes University Hospital. Since September 2015, he has been instrumental in advancing cardiovascular care, overseeing the Cardiac Diagnostic and Interventional Unit and leading the Cardiology Research Unit. His previous role as Assistant Professor in the intensive care unit at the same hospital laid a strong foundation for his clinical expertise. With a commitment to teaching, Barone-Rochette has educated medical students and residents in cardiovascular disease and imaging, fostering the next generation of healthcare professionals.

Research Contributions :

As the leader of various research units, including the Cardiology Research Unit and the Competence Centre for Cardiomyopathies, Barone-Rochette has significantly contributed to cardiology research. His involvement in projects focused on cardiovascular imaging and interventional cardiology showcases his innovative approach and capacity for collaborative research efforts, further solidifying his status as an influential researcher.

Award And Recognition :

Gilles Barone-Rochette has been recognized for his outstanding contributions to cardiology and medical education. As a professor at Grenoble Alpes University Hospital, he has led numerous groundbreaking research initiatives in cardiovascular imaging and cardiomyopathies, earning him accolades from both national and international medical societies. His commitment to training future cardiologists has been acknowledged through multiple teaching awards, reflecting his impact on medical education. Barone-Rochette’s active involvement in prestigious organizations, including the French Society of Cardiology and the European Society of Cardiology, further highlights his dedication to advancing cardiovascular research and improving patient care in the field.

Conclusion :

Given Gilles Barone-Rochette’s exemplary qualifications, impactful research, and unwavering commitment to education, he stands out as an exceptional candidate for the Research for Excellence in Research award. His contributions to cardiology research and his leadership in training future healthcare professionals position him as a valuable asset to the medical community and a worthy recipient of this recognition.

Publication Top Notes :

Coronary microvascular dysfunction and atrial reservoir function 🌟 – Citations: 0 – Year: 2024
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial 📊 – Citations: 4 – Year: 2024
Is coronary artery disease screening by imaging in patients with chronic kidney disease necessary? ❓ – Citations: 0 – Year: 2024
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial 📈 – Citations: 0 – Year: 2024
New Method CMR-Guided Endomyocardial Biopsy in Suspicion Context of Isolated Cardiac Sarcoidosis 🧬 – Citations: 0 – Year: 2024
Coronary disorder is not necessarily caused exclusively by coronary microvascular dysfunction in hypertrophic cardiomyopathy 🔍 – Citations: 0 – Year: 2024
Myocardial Infarction with no obstructive coronary arteries: Imaging plays a central role ❤️ – Citations: 0 – Year: 2024
Coronary microvascular dysfunction as assessed by multimodal diagnostic imaging in patients with hypertrophic cardiomyopathy is related to the severity of cardiac dysfunction 📉 – Citations: 0 – Year: 2024
Segmentation of cardiac infarction in delayed-enhancement MRI using probability map and transformers-based neural networks 🖥️ – Citations: 1 – Year: 2023
Assessment of the Objective Effect of Virtual Reality for Preoperative Anxiety in Interventional Cardiology 🎮 – Citations: 0 – Year: 2023

Ashwani Singal | Medicine and Dentistry | Best Researcher Award

Posted on 12/10/202412/10/2024 by ScienceFather

Ashwani Singal | Medicine and Dentistry | Best Researcher Award

Prof Ashwani Singal, University of Louisville School of Medicine, United States

Prof. Ashwani Singal, he appears to be a highly suitable candidate for the Best Researcher Award. Here are several reasons supporting this nomination:

Publication Profile

Google Scholar

Research and Academic Excellence

Extensive Education: Prof. Singal holds an MBBS, MD in Medicine, and a DM in Gastroenterology, along with postdoctoral training in Transplant Hepatology and Gastroenterology from prestigious institutions like Mayo Clinic and UTMB Galveston.
Publications: He has a substantial publication record, including influential papers on liver diseases, alcoholic liver disease, and hepatitis C, demonstrating his contributions to advancing medical knowledge in his field. His work has been recognized in reputable journals and conferences, with multiple posters of distinction presented at AASLD annual conferences.

Clinical Impact

Leadership Roles: As the Medical Director of Liver Transplant at the Trager Transplant Institute and a Transplant Hepatologist at Avera Transplant Institute, he plays a critical role in clinical practice and patient care, impacting many lives.
Current Support: His involvement in multiple funded research projects indicates ongoing commitment to advancing research in alcohol use disorders and liver diseases, with significant financial backing from NIH and other organizations.

Contributions to Medical Education

Teaching and Mentoring: Prof. Singal has extensive experience in teaching medical students and residents across various institutions, having served as a course director and providing numerous lectures and grand rounds. His mentorship has led to several mentees receiving awards for their research.

Professional Engagement

Committee Involvement: He has served on numerous committees and councils within professional societies, showcasing his dedication to improving the field of gastroenterology and hepatology.
Editorial Roles: Prof. Singal is active in the editorial boards of reputable journals, contributing to the peer-review process and shaping future research directions in his specialty.

Recognition and Awards

Recent Nominations: His nomination for the Clinical Innovation Award by the Healio-American College of Gastroenterology and his status as an International Fellow of the National Academy of Medical Science in India highlight his recognition as a leader in his field.

Publication Top Notes

ACG clinical guideline: alcoholic liver disease

The Bioenergetic Health Index: a new concept in mitochondrial translational research

Evolving frequency and outcomes of liver transplantation based on etiology of liver disease

Antioxidants as therapeutic agents for liver disease

Hepatitis C virus and hepatocellular carcinoma: a narrative review

Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus–related cirrhosis

Mesenteric venous thrombosis

Conclusion

Prof. Ashwani Singal’s extensive academic credentials, significant clinical contributions, commitment to education, active engagement in professional societies, and recognition in the form of awards and nominations make him an exemplary candidate for the Best Researcher Award. His work not only contributes to advancing medical knowledge but also directly impacts patient care and the training of future healthcare professionals.

Gagan Mathur | Medicine and Dentistry Award | Best Researcher Award

Posted on 29/08/202429/08/2024 by ScienceFather

Assoc Prof Dr. Gagan Mathur | Medicine and Dentistry Award | Best Researcher Award

Assoc Prof Dr. Gagan Mathur, University of California Irvine, United States

Assoc Prof Dr. Gagan Mathur: Candidate for Best Researcher Award Evaluation

Publication profile

Google Scholar

Employment History

Dr. Gagan Mathur is a highly experienced professional with a strong background in transfusion medicine and clinical pathology. Since December 2022, he has served as the Medical Director of Transfusion Medicine-Blood Bank at the University of California Irvine School of Medicine, where he also holds the role of Associate Program Director of the Pathology Residency Program. He has previously held prominent positions at the Children’s Hospital Los Angeles and Saint Luke’s Health System in Kansas City, demonstrating his leadership and expertise in managing complex medical and educational settings.

Post-Graduate Training and Education

Dr. Mathur’s rigorous academic background includes a fellowship in Transfusion Medicine/Blood Banking and a residency in Clinical Pathology at the University of Iowa Hospitals & Clinics. He also holds an MBA from the University of Iowa, which complements his medical expertise with business acumen. His foundational medical education was completed at Dr. S.N. Medical College in India.

Certifications and Licensure

Dr. Mathur is board-certified in both Transfusion Medicine/Blood Banking and Clinical Pathology by the American Board of Pathology. He holds medical licenses in California and previously held licenses in Missouri, Kansas, and Iowa. His certification as a Certified Physician Executive underscores his commitment to leadership in healthcare.

Awards and Distinctions

Dr. Mathur has been recognized for his contributions to medicine with numerous accolades, including being named a Top Pathologist by Best in California Magazine in 2023 and a multiple nominee for the Orange County Physician of Excellence award. His early recognition includes the Paul E. Strandjord Young Investigator Award and an Outstanding Reviewer award from a leading scientific journal.

Teaching and Mentoring

Dr. Mathur is actively involved in teaching and mentoring the next generation of medical professionals. He serves as an Associate Program Director and Chair of the Clinical Competency Committee in the Pathology Residency Program at UC Irvine. He also contributes as a faculty member in various transfusion medicine and blood banking courses for medical students, residents, fellows, and clinical laboratory scientist students.

Publication Top Notes

Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22 (Journal of Analytical Toxicology) – Cited by 206, 2014 🧪📊
Antibody testing for COVID-19: can it be used as a screening tool in areas with low prevalence? (American Journal of Clinical Pathology) – Cited by 90, 2020 🦠🔬
High clinical suspicion of donor‐derived disease leads to timely recognition and early intervention to treat solid organ transplant‐transmitted lymphocytic choriomeningitis virus (Transplant Infectious Disease) – Cited by 29, 2017 🏥🦠
Use of a data warehouse at an academic medical center for clinical pathology quality improvement, education, and research (Journal of Pathology Informatics) – Cited by 25, 2015 📈🧑‍💻
Clinical profile and mortality among novel influenza A (H1N1) infected patients: 2009-2010 Jodhpur, Rajasthan pandemic (Journal of the Association of Physicians of India) – Cited by 25, 2013 🏥🌍
Antibody testing for COVID-19 (American Journal of Clinical Pathology) – Cited by 7, 2020 🦠🧬
Factors influencing platelet clumping during peripheral blood hematopoietic stem cell collection (Transfusion) – Cited by 7, 2017 🩸🔬
A clinico-epidemiologic study of neurologic associations and factors related to speech and language delay (National Journal of Community Medicine) – Cited by 7, 2012 🧠🗣️
Solutions to technical challenges during therapeutic plasma exchange using the Spectra Optia on a 4 kilogram neonate (Transfusion and Apheresis Science) – Cited by 5, 2018 🍼🩸
Streamlined sign-out of capillary protein electrophoresis using middleware and an open-source macro application (Journal of Pathology Informatics) – Cited by 5, 2014 🧬💻
A case for a national registry of red blood cell antibodies (Vox Sanguinis) – Cited by 4, 2022 🩸🧾
Predicting changes in hemoglobin S after simple transfusion using complete blood counts (Transfusion) – Cited by 3, 2018 🩸🧪
A case cluster of lymphocytic choriomeningitis virus transmitted via organ transplantation (Transplantation) – Cited by 2, 2014 🦠🏥

Conclusion

Assoc Prof Dr. Gagan Mathur’s extensive experience, academic background, and leadership roles make him a strong candidate for the Best Researcher Award. His contributions to transfusion medicine, combined with his teaching and mentoring roles, demonstrate a commitment to advancing medical science and education. His recognition by peers and multiple accolades further support his suitability for this prestigious award

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Posted on 23/08/202423/08/2024 by ScienceFather

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Dr Cristina Papayannidis, IRCCS, Azienda Ospedaliero Universitaria S.Orsola Malpighi, Bologna, Italy, Italy

Dr. Cristina Papayannidis appears to be an outstanding candidate for the Best Researcher Award based on several key criteria:

Publication profile

scopus

Extensive Experience

Dr. Papayannidis has been deeply involved in clinical research and patient care in hematology since her early career. Her role as Dirigente Medico Ematologia at IRCCS Azienda Ospedaliero Universitaria di Bologna highlights her leadership in AML and ALL clinical trials.

High Research Output

She has authored over 130 publications and has been a principal or sub-investigator in more than 60 phase 1-3 clinical trials, showcasing her significant contributions to advancing hematology research.

Recognition and Influence

With an H-index of 34, she has made substantial impacts in her field. Her role as a speaker at over 300 national and international events, including prestigious conferences like ASH and EHA, underscores her influential presence in the hematological community.

Mentorship and Leadership

Her positions as a mentor in EHA Master Classes and member of various working groups demonstrate her commitment to guiding the next generation of researchers and shaping the future of hematology.

Professional Memberships

Memberships in esteemed organizations such as SIE, EHA, and AACR, and her role on the Hematological Malignancies Committee ESMO further reflect her prominent status and active participation in the scientific community.

Dr. Papayannidis’s extensive research experience, high publication volume, significant impact on clinical practice, and active involvement in mentorship and professional societies make her a highly suitable candidate for the Best Researcher Award.

Research focus

The research focus of the individuals associated with these articles centers on hematological malignancies and their management. They investigate advanced treatments and strategies for diseases like acute lymphoblastic leukemia (ALL), particularly in the context of drug therapies and stem cell transplantation. Key topics include evaluating the efficacy of ponatinib versus imatinib in treating Philadelphia chromosome-positive ALL, using ponatinib to prevent relapse after transplantation, and assessing the impact of inotuzumab ozogamicin on outcomes and complications in refractory cases. Their work contributes to improving therapeutic approaches and patient outcomes in hematology. 🩺💉🔬

Publication top notes

Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)

Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission †

Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease

Rainer Pooth | Medicine and Dentistry Award | Best Innovation Award

Posted on 09/08/202409/08/2024 by ScienceFather

Dr. Rainer Pooth | Medicine and Dentistry Award | Best Innovation Award

Dr. Rainer Pooth, ICAAN GmbH, Germany

Based on the information provided, Dr. Rainer Pooth appears to be a highly suitable candidate for the “Research for Best Innovation Award” in the pharmaceutical and medical industry. Here’s an assessment of his qualifications:

Publication profile

Scopus

Orcid

Professional Experience & Leadership

Dr. Pooth has over 20 years of experience in the global pharmaceutical and medical industry, with a strong track record of leadership in multidisciplinary teams at both global and affiliate levels. His roles as Managing Director, Global Head of Medical/Scientific Affairs, and Head of Global Clinical Development demonstrate his ability to lead and innovate in complex, highly regulated environments. His strategic input in global R&D programs, project management, and regulatory affairs underscores his expertise in driving innovation and ensuring successful product development.

Achievements & Expertise

Dr. Pooth’s achievements include multiple approvals of medicinal products and medical devices across key global markets such as the EU, US, Australia, and Asia. He holds more than 35 patents, with a significant portion becoming commercially relevant, highlighting his innovative contributions to the field. His extensive publication record, including over 50 publications in international journals and books, as well as his role as an invited speaker at major scientific congresses, further cements his reputation as a leader in pharmaceutical research and innovation.

Global Impact & Collaboration

Dr. Pooth’s global network of experts and key opinion leaders, along with his experience in managing international submission teams and regulatory interactions, illustrates his ability to navigate and influence the global pharmaceutical landscape. His leadership in directing high-level global teams and managing collaborations with regulatory authorities and contract research organizations (CROs) demonstrates his capability to bring innovative products to market successfully.

Publication Top Notes

“Treatment of Refractory Cardiac Arrest by Controlled Reperfusion of the Whole Body” – A study exploring CARL in a multicenter setting, highlighting its impact on refractory cardiac arrest patients (2023).
“The Impact of Head Position on Neurological and Histopathological Outcome Following CARL” – Investigates how head positioning affects outcomes in a pig model during CARL (2023).
“Extracorporeal Cardiopulmonary Resuscitation—Evidence and Implications” – Discusses ECPR’s evidence base and its clinical implications (2023).
“Effects of Prolonged Serum Calcium Suppression during ECPR in Pigs” – Examines the effects of serum calcium suppression during ECPR, showing implications for treatment strategies (2023).
“Limiting Calcium Overload after Cardiac Arrest” – Focuses on the role of albumin in reducing calcium overload during CARL (2023).
“Pervasive Platelet Secretion Defects in SARS-CoV-2 Patients” – Analyzes platelet defects in COVID-19 patients and their potential implications for treatment (2023).
“CARL – Controlled Reperfusion of the Whole Body” – A book detailing the CARL procedure, providing a comprehensive resource for clinicians (2022).
“Observational Study on Implications of the COVID-19-Pandemic for Cardiopulmonary Resuscitation” – Examines the pandemic’s impact on resuscitation practices, offering valuable insights (2022).
“Monitoring Mitochondrial Partial Oxygen Pressure During Cardiac Arrest and ECPR” – A pilot study exploring mitochondrial oxygen monitoring during cardiac arrest in a pig model (2021).
“Brain Vulnerability and Viability after Ischaemia” – A review on the neurological outcomes following ischemic events, highlighting vulnerabilities and potential treatment avenues (2021).

Conclusion

Dr. Pooth’s extensive experience, significant contributions to the development and approval of innovative pharmaceutical products, and his leadership in global research and development make him a strong candidate for the “Research for Best Innovation Award.” His work has had a substantial impact on multiple therapeutic areas, including dermatology, immunology, aesthetic medicine, oncology, and neurology, making him well-deserving of recognition in this prestigious category.

Enguo Cao | Health Professions | Best Researcher Award

Posted on 24/07/202424/07/2024 by ScienceFather

Enguo Cao | Health Professions | Best Researcher Award

Prof Dr Enguo Cao, Jiangnan University, China

Prof. Cao Enguo 🧑‍🏫 is a distinguished professor and doctoral supervisor at Jiangnan University, China. With a Ph.D. from Japan, he leads the Intelligent Interaction Design Laboratory and serves as deputy director of the Key Laboratory of China Light Industry. His research focuses on intelligent product design and human biomimetic interaction, resulting in over 30 papers and 20+ patents. He has led numerous research projects, including grants from the National Natural Science Foundation of China. Prof. Cao has earned several accolades, including the Yoneyama Rotary Memorial Award and the title of “Top Six Talent Peaks” in Jiangsu Province. 🌟🔬📚

Publication profile

Scopus

Research Interests

Intelligent Interaction System Design focuses on creating advanced systems that enhance user experiences through smart and responsive technology. This field encompasses the development of interactive interfaces that adapt to user needs, leveraging artificial intelligence and machine learning to offer intuitive and personalized interactions. The goal is to build systems that not only respond to user inputs but also predict and adapt to their preferences, providing a seamless and engaging experience. Such designs are pivotal in various applications, from smart home devices to sophisticated customer service bots, aiming to make technology more accessible and user-friendly.

Research focus

Dr. Enguo Cao’s research primarily focuses on wearable health devices, exoskeleton design, and user experience in robotics. His work includes designing and evaluating various types of exoskeletons for rehabilitation and mobility enhancement, such as passive lower limb exoskeletons and multi-resiliency models. He also explores the integration of emotional and social factors into user experience, aiming to improve interaction with automated systems and devices. His contributions include studies on the physiological effects of exoskeletons during physical activities and data-driven frameworks for predicting user expectations. His research is crucial for advancing assistive technologies and enhancing their practical application. 🤖🦵📊

Publication top notes

User Experience & Usability of Wearable Health Device: A Bibliometric Analysis of 2014–2023

Multi-motion Compound Passive Lower Limb Exoskeleton Design and Its Intelligent Interaction Evaluation

Design and evaluation of a double rope rehabilitation robot for sit-to-stand training

Exploring the Positive User Experience Possibilities Based on Produc

Design of a multi-resiliency exoskeleton and its physiologic cost evaluation in uphill walking and stair climbing locomotion

A Data-Driven Expectation Prediction Framework Based on Social Exchange Theory

Design and performance evaluation of gravitational potential energy locking exoskeleton

Design of cyber-physical-social systems with forensic-awareness based on deep learning

Design and optimization of a passive exoskeleton mechanical foot

Jianglan Long | Medicine and Dentistry | Best Innovation Award

Posted on 10/06/202410/06/2024 by ScienceFather

Jianglan Long | Medicine and Dentistry | Best Innovation Award

Dr Jianglan Long,Beijing Institute of Clinical Pharmacy, Beijing Friendship Hospital, Capital Medical University,China

Dr. Jianglan Long is a dedicated Researcher Intern at Beijing Institute of Clinical Pharmacy, affiliated with Beijing Friendship Hospital and Capital Medical University. Specializing in intelligent molecular diagnostics and drug intervention mechanisms for pre-diabetes and type 2 diabetes, Dr. Long has published several impactful papers. Notable works include studies in International Journal of Biological Macromolecules (2024) on innovative diabetes treatments, and contributions to Diabetes Obesity & Metabolism (2024) on predictive biomarker profiling. Dr. Long is a pioneer in developing integrated diagnostic tools and advancing diabetes treatment in China. 🌟🔬📚

Publication profile

Scopus

Academic and Professional Background

Dr. Jianglan Long is a prominent researcher based at the Beijing Institute of Clinical Pharmacy, affiliated with Beijing Friendship Hospital, Capital Medical University. His primary focus lies in the exploration of intelligent molecular diagnosis and drug intervention mechanisms for prediabetes and type 2 diabetes. Dr. Jianglan Long has made significant contributions to this field, evidenced by his publications in reputable journals such as the International Journal of Biological Macromolecules (2024), Diabetes Obesity & Metabolism (2024), Clinical and Translational Medicine (2021), BMC Endocrine Disorders (2020), and Rapid Communications in Mass Spectrometry (2020), where he served as the first author.

Research focus

Category: Research Focus on Intelligent Molecular Diagnosis and Drug Intervention for Diabetes

Jianglan Long’s research centers on advancing the field of intelligent molecular diagnostics and drug interventions for pre-diabetes and type 2 diabetes. Her work includes pioneering biomarker profiling for early disease detection and the enhancement of metformin therapy with innovative treatments, like low molecular weight polysaccharides from Astragalus membranaceus. With twelve published journals and ongoing research, her contributions are crucial for improving diabetes management and treatment outcomes in China and potentially worldwide. 📊🔬💊🌍

Publication top notes

Structural characterization of Astragalus polysaccharide-D1 and its improvement of low-dose metformin effect by enriching Staphylococcus lentus

Uncovering the key pharmacodynamic material basis and possible molecular mechanism of Xiaoke formulation improve insulin resistant through a comprehensive investigation

Rapid multichannel fluorescent probe assay for CYP450 inhibition screening and drug interaction monitoring

Novel weight loss diet attenuates dietary-induced obesity in mice and might correlate with altered gut microbiota and metabolite profiles

Polystyrene microplastic exposure induces insulin resistance in mice via dysbacteriosis and pro-inflammation

Evaluation of interaction of chlorogenic acid and cefotaxime sodium based on sequential analysis

Network pharmacology-based dissection of the underlying mechanisms of dyspnoea induced by zedoary turmeric oil

Metabolomics based plasma biomarkers for diagnosis of oral squamous cell carcinoma and oral erosive lichen planus

Dan Yan | Medicine and Dentistry | Best Researcher Award

Posted on 10/06/202410/06/2024 by ScienceFather

Dan Yan | Medicine and Dentistry | Best Researcher Award

Prof Dan Yan,Beijing Friendship Hospital, Capital Medical University,China

Prof. Dan Yan, Ph.D., is a leading figure in clinical pharmacy and precision medicine at Beijing Institute of Clinical Pharmacy, China. 🌟 With a robust background in traditional Chinese medicine and a Ph.D. from Chengdu University, he specializes in intelligent molecular diagnosis and combined medication for chronic metabolic diseases. 🧬 His groundbreaking research focuses on optimizing diabetes treatment, particularly exploring multi-drug combinations and personalized therapies. As a prolific author and committee member of prestigious scientific organizations, Prof. Yan is dedicated to advancing healthcare through innovative research and evidence-based practices. 📚✨

Publication profile

Scopus

Education

Prof. Dan Yan pursued an extensive educational journey at Chengdu University of Traditional Chinese Medicine, culminating in a Ph.D. from 2004 to 2007. Prior to his doctoral studies, he obtained his Master of Science degree from the same institution between 2001 and 2004. Prof. Yan’s academic pursuits trace back to his undergraduate years, where he completed his Bachelor of Science degree from 1994 to 1998, laying the foundation for his subsequent advanced studies. His educational background reflects a dedicated commitment to traditional Chinese medicine, fostering a deep expertise in this field.

Research focus

Prof. Dan Yan’s research focuses on the intelligent molecular diagnosis and combined medication for chronic metabolic diseases, particularly pre-diabetes and type 2 diabetes. His work leverages multi-omics approaches, such as metabolomics, to enhance early diagnosis and personalized treatment strategies. He aims to optimize drug combinations from a broad range of hypoglycemic drugs, including traditional and novel therapies. This research not only addresses the declining efficacy of long-term metformin use but also integrates pharmacoeconomics and evidence-based medicine to improve clinical outcomes in diabetes care.

Publication top notes

Structural characterization of Astragalus polysaccharide-D1 and its improvement of low-dose metformin effect by enriching Staphylococcus lentus

A systematic review on the appropriate discounting rates for the economic evaluation of gene therapies: Whether a specific approach is justified to tackle the challenges?

Antibiotic combinations predicti on based on machine learning to multicentre clinical data and drug interaction correlation

Uncovering the key pharmacodynamic material basis and possible molecular mechanism of Xiaoke formulation improve insulin resistant through a comprehensive investigation

Rapid multichannel fluorescent probe assay for CYP450 inhibition screening and drug interaction monitoring

QALY-type preference and willingness-to-pay among end-of-life patients with cancer treatments: a pilot study using discrete choice experiment

β-Elemene in zedoary turmeric oil injection induces dyspnea by binding to hemoglobin and upregulating HIF-1α

Predicting coronary heart disease in Chinese diabetics using machine learning

Editorial: Benefits and risks of drug combination therapy for chronic metabolic diseases

Quality assessment and control of Shuanghuanglian Lyophilized Injection based on cell response spectrum

Zhenhan Deng | Medicine and Dentistry | Best Researcher Award

Posted on 08/06/202411/06/2024 by ScienceFather

Zhenhan Deng | Medicine and Dentistry | Best Researcher Award

Dr Zhenhan Deng, The First Affiliated Hospital of Wenzhou Medical University, China

Dr. Zhenhan Deng is a distinguished orthopedic surgeon born on July 19, 1989. He currently serves as a Deputy Chief Physician at The First Affiliated Hospital of Wenzhou Medical University in China 🇨🇳. Dr. Deng completed his Ph.D. at Xiangya Hospital, CSU, and was a visiting scholar at the University of Texas Health Science Center 🏥. His research focuses on osteoarthritis and cartilage regeneration, supported by significant grants and notable publications 📚. He has received multiple awards, including the Orthopaedic Research Society’s New Investigator Recognition Award and the Shenzhen Health Elite Talent title 🌟. For more details, visit his official website 🌐.

Publication profile

google scholar

Education

Deng pursued his Ph.D. in Orthopedics at Xiangya Hospital, Central South University (CSU), Hunan, China, from September 2015 to November 2018. Additionally, he was a Visiting Scholar at the University of Texas Health Science Center at Houston, focusing on Orthopedics, from December 2016 to September 2018. Prior to his doctoral studies, Deng completed his Master of Medicine and Bachelor of Medicine degrees at Xiangya Hospital, CSU.

Work Experience

Throughout his career, Deng has held various positions in orthopedic surgery and sports medicine. He served as a Deputy Chief Physician in the Department of Orthopedic Surgery at The First Affiliated Hospital of Wenzhou Medical University from December 2023 to September 2023. Prior to this, he worked as an Attending Physician in the same department. Deng also gained experience as an Attending Physician in the Department of Sports Medicine at Shenzhen Second People’s Hospital, Shenzhen, Guangdong, China, from September 2020 to September 2023, after starting as a Resident Physician in December 2018.

Awards

Deng has received numerous awards and honors for his contributions to orthopedic research and clinical practice. Notable accolades include being nominated for the Orthopaedic Research Society (ORS) New Investigator Recognition Awards (NIRA), winning the Orthopaedic Research Society (ORS) ON Foundation/ORS Orthoregeneration Award, and receiving recognition as an Outstanding Graduate of Hunan Province.

Research focus

Zhenhan Deng is an orthopaedic surgeon and researcher focused on advancing treatments for musculoskeletal conditions, particularly osteoarthritis and cartilage repair. His research encompasses the development of innovative therapies, such as microgel scaffolds, mesenchymal stem cells, and gene therapy to promote cartilage regeneration and joint repair. Deng’s work includes investigating the roles of various signaling pathways in disease progression and treatment efficacy. His projects and publications underscore his commitment to improving patient outcomes through cutting-edge, translational medical research. 🩺🦴🧬🔬💡🌟

For further information, you can visit his personal work website at https://dzhdr.haodf.com/.

Publication top notes

Electrical stimulation for pain relief in knee osteoarthritis: systematic review and network meta-analysis
C Zeng, T Yang, Z Deng, Y Yang, Y Zhang, G Lei
Osteoarthritis and Cartilage, 2015 – 179 citations 📊
Effectiveness of continuous and pulsed ultrasound for the management of knee osteoarthritis: a systematic review and network meta-analysis
C Zeng, H Li, T Yang, ZH Deng, Y Yang, Y Zhang, X Ding, GH Lei
Osteoarthritis and Cartilage, 2014 – 158 citations 📉
Macrophages in osteoarthritis: pathophysiology and therapeutics
Y Chen, W Jiang, H Yong, M He, Y Yang, Z Deng, Y Li
American Journal of Translational Research, 2020 – 118 citations 🦠
Bone morphogenetic proteins for articular cartilage regeneration
ZH Deng, YS Li, X Gao, GH Lei, J Huard
Osteoarthritis and Cartilage, 2018 – 103 citations 💉
The role of sirtuin 1 and its activator, resveratrol in osteoarthritis
Z Deng, Y Li, H Liu, S Xiao, L Li, J Tian, C Cheng, G Zhang, F Zhang
Bioscience Reports, 2019 – 97 citations 🍇
Long noncoding RNAs in osteoarthritis
J Lu, Z Deng, Y Li, G Lei
Joint Bone Spine, 2017 – 88 citations 🧬
Cartilage tissue engineering: From proinflammatory and anti‑inflammatory cytokines to osteoarthritis treatments
S Liu, Z Deng, K Chen, S Jian, F Zhou, Y Yang, Z Fu, H Xie, J Xiong, …
Molecular Medicine Reports, 2022 – 86 citations 🦴
Is posterior tibial slope associated with noncontact anterior cruciate ligament injury?
C Zeng, T Yang, S Wu, S Gao, H Li, Z Deng, Y Zhang, G Lei
Knee Surgery, Sports Traumatology, Arthroscopy, 2016 – 81 citations 🏃‍♂️
Characterization of a novel polyvinyl alcohol/chitosan porous hydrogel combined with bone marrow mesenchymal stem cells and its application in articular cartilage repair
L Peng, Y Zhou, W Lu, W Zhu, Y Li, K Chen, G Zhang, J Xu, Z Deng, …
BMC Musculoskeletal Disorders, 2019 – 73 citations 💧
Association between dietary magnesium intake and radiographic knee osteoarthritis
C Zeng, H Li, J Wei, T Yang, Z Deng, Y Yang, Y Zhang, T Yang, G Lei
PLoS One, 2015 – 70 citations 🍽️
RhoA/ROCK pathway: implication in osteoarthritis and therapeutic targets
Z Deng, Y Jia, H Liu, M He, Y Yang, W Xiao, Y Li
American Journal of Translational Research, 2019 – 67 citations 🔬
MALAT1 promotes osteosarcoma development by targeting TGFA via MIR376A
W Luo, H He, W Xiao, Q Liu, Z Deng, Y Lu, Q Wang, Q Zheng, Y Li
Oncotarget, 2016 – 65 citations 🎯
Alterations of amino acid metabolism in osteoarthritis: its implications for nutrition and health
Y Li, W Xiao, W Luo, C Zeng, Z Deng, W Ren, G Wu, G Lei
Amino Acids, 2016 – 63 citations 🍽️
Modified arthroscopic Latarjet procedure: suture-button fixation achieves excellent remodeling at 3-year follow-up
J Xu, H Liu, W Lu, Z Deng, W Zhu, L Peng, K Ouyang, H Li, D Wang
The American Journal of Sports Medicine, 2020 – 58 citations 🏅
MicroRNA-199a-5p inhibits cisplatin-induced drug resistance via inhibition of autophagy in osteosarcoma cells
Y Li, W Jiang, Y Hu, Z Da, C Zeng, M Tu, Z Deng, W Xiao
Oncology Letters, 2016 – 53 citations 🚫
MicroRNA-379 inhibits the proliferation, migration and invasion of human osteosarcoma cells by targetting EIF4G2
X Xie, YS Li, WF Xiao, ZH Deng, HB He, Q Liu, W Luo
Bioscience Reports, 2017 – 51 citations 🛡️
MicroRNA-127-5p regulates osteopontin expression and osteopontin-mediated proliferation of human chondrocytes
M Tu, Y Li, C Zeng, Z Deng, S Gao, W Xiao, W Luo, W Jiang, L Li, G Lei
Scientific Reports, 2016 – 50 citations 🧫
p38MAPK signaling pathway in osteoarthritis: pathological and therapeutic aspects
Z Li, A Dai, M Yang, S Chen, Z Deng, L Li
Journal of Inflammation Research, 2022 – 45 citations 🌡️
Diet-intestinal microbiota axis in osteoarthritis: a possible role
Y Li, W Luo, Z Deng, G Lei
Mediators of Inflammation, 2016 – 45 citations 🔗
Relationship between cigarette smoking and radiographic knee osteoarthritis in Chinese population: a cross-sectional study
Y Zhang, C Zeng, H Li, T Yang, Z Deng, Y Yang, X Ding, D Xie, Y Wang, …
Rheumatology International, 2015 – 45 citations 🚬

Each line provides the title of the paper, the authors, the journal it was published in, the year of publication, the number of citations, and an emoji representing the general theme or content of the paper.